Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures.
Giagulli VA, Triggiani V, Corona G, Carbone MD, Tafaro E, Licchelli B, Resta F, Sabbà C, Maggi M, Guastamacchia E. Giagulli VA, et al. Among authors: licchelli b. Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):236-42. doi: 10.2174/187153012802002866. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 22385118 Clinical Trial.
Hypopituitarism in Neurocritical Patients: A Case Report.
Iovino M, Iovine N, Mondillo F, Guastamacchia E, Licchelli B, Giagulli VA, Triggiani V. Iovino M, et al. Among authors: licchelli b. Endocr Metab Immune Disord Drug Targets. 2016;16(1):28-31. doi: 10.2174/1871530315666150930121912. Endocr Metab Immune Disord Drug Targets. 2016. PMID: 26420547
Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets.
Guastamacchia E, Resta F, Mangia A, Schittulli F, Ciampolillo A, Triggiani V, Licchelli B, Paradiso A, Sabbà C, Tafaro E. Guastamacchia E, et al. Among authors: licchelli b. Curr Drug Targets Immune Endocr Metabol Disord. 2003 Sep;3(3):205-9. doi: 10.2174/1568008033340199. Curr Drug Targets Immune Endocr Metabol Disord. 2003. PMID: 12871027
Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors.
Guastamacchia E, Resta F, Triggiani V, Liso A, Licchelli B, Ghiyasaldin S, Sabbà C, Tafaro E. Guastamacchia E, et al. Among authors: licchelli b. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):59-66. doi: 10.2174/1568008043339965. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15032627 Review.
The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention.
Resta F, Triggiani V, Sabbà C, Licchelli B, Ghiyasaldin S, Liso A, Schittulli F, Quaranta M, Paradiso A, Tafaro E, Guastamacchia E. Resta F, et al. Among authors: licchelli b. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Dec;4(4):327-33. doi: 10.2174/1568008043339686. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15578984
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects?
Iovino M, Triggiani V, Giagulli VA, Iovine N, Licchelli B, Resta F, Sabbà C, Tafaro E, Solimando A, Tommasicchio A, Guastamacchia E. Iovino M, et al. Among authors: licchelli b. Immunopharmacol Immunotoxicol. 2011 Jun;33(2):334-7. doi: 10.3109/08923973.2010.510844. Epub 2010 Sep 16. Immunopharmacol Immunotoxicol. 2011. PMID: 20843274
40 results